Manchester Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.05K | Hold |
237
| – | – | ﹤0.01% | 932 |
|
2025
Q1 | $15.1K | Hold |
237
| – | – | ﹤0.01% | 767 |
|
2024
Q4 | $28.8K | Buy |
237
+110
| +87% | +$13.4K | ﹤0.01% | 655 |
|
2024
Q3 | $15.9K | Hold |
127
| – | – | ﹤0.01% | 721 |
|
2024
Q2 | $20.1K | Buy |
127
+125
| +6,250% | +$19.8K | ﹤0.01% | 657 |
|
2024
Q1 | $259 | Hold |
2
| – | – | ﹤0.01% | 984 |
|
2023
Q4 | $193 | Sell |
2
-1
| -33% | -$97 | ﹤0.01% | 974 |
|
2023
Q3 | $364 | Hold |
3
| – | – | ﹤0.01% | 923 |
|
2023
Q2 | $344 | Buy |
+3
| New | +$344 | ﹤0.01% | 904 |
|
2021
Q1 | – | Sell |
-3
| Closed | -$1K | – | 770 |
|
2020
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 696 |
|
2019
Q2 | – | Sell |
-570
| Closed | -$68K | – | 634 |
|
2019
Q1 | $68K | Buy |
+570
| New | +$68K | 0.01% | 358 |
|
2014
Q2 | – | Sell |
-83
| Closed | -$2K | – | 1105 |
|
2014
Q1 | $2K | Buy |
+83
| New | +$2K | ﹤0.01% | 967 |
|